Erratum: Gradual Titration of Semaglutide Results in Better Treatment Adherence and Fewer Adverse Events: A Randomized Controlled Open-Label Pilot Study Examining a 16-Week Flexible Titration Regimen Versus Label-Recommended 8-Week Semaglutide Titration Regimen (Diabetes Care (2025), 48, (1607–1611), 10.2337/dc25-0690)
- Roy Eldor
- , Noa Avraham
- , Orit Rosenberg
- , Miriam Shpigelman
- , Avivit Golan-Cohen
- , Tali Cukierman-Yaffe
- , Eugene Merzon
- , Assaf Buch
نتاج البحث: نشر في مجلة › تعليقَ / نقاش